Inventiva cuts first-half 2026 net loss to €69.5 million

Verifying
  • Inventiva reported improved financial results for the first half of 2026.
  • €69.5 million was the net loss, down from €175.9 million previously.
  • Inventiva completed the final patient visit in its Phase 3 NATiV3 MASH trial.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Inventiva cuts first-half 2026 net loss to €69.5 million - CoinPost Terminal